Join the webinar

Accessing international markets for biological agricultural products involves navigating different regulatory requirements, timelines, and data expectations. Developing a global strategy for biocontrol market access from the early stages of product development can help companies optimize regulatory studies, investments, and commercialization timelines.

The United States, Brazil, and the European Union each have their own regulatory frameworks. However, treating each market as a completely separate project can lead to duplicated studies, higher R&D costs, and delays in bringing products to market.

A coordinated approach allows companies to consider different regulatory requirements from the outset and assess how a core data package can support market-specific regulatory strategies.

How can regulatory strategies be aligned across markets?

This will be one of the key topics discussed during Staphyt BioTeam’s webinar, “Think Global, Act Phased: Accelerating Biocontrol Market Access through Synergy”, taking place on October 8, 2026, at 15:00 CET.

During the session, our experts, Anna Armstrong, Daniela Maia, and Amélie Grimaldi, Principal Consultant, will discuss strategies for coordinating regulatory planning across the United States, Brazil, and the European Union, while taking into account the specific requirements of each market.

Key topics will include:

• Building a core data package to support different regulatory strategies;
• Planning studies and data generation around the requirements of multiple jurisdictions;
• Prioritizing markets to identify earlier commercialization opportunities;
• Integrating product development, data generation, and regulatory strategy;
• Reducing redundant efforts and optimizing R&D investments.

From global planning to market execution

A global strategy does not necessarily mean pursuing registration in every market at the same time. Instead, it means understanding the different regulatory pathways and establishing a logical sequence for product development and market entry based on the product, available data, and commercial objectives.

The webinar will provide a strategic framework for approaching this process. It will also offer an opportunity to continue the conversation at ABIM in October, where the Staphyt team will be available to discuss specific pipelines, products, and international market access challenges.

Join the webinar

Discover how a coordinated regulatory strategy can help your company plan international market access for biological products more efficiently.

October 8, 2026

Sign up for the webinar for free:

https://staphyt.clickmeeting.com/global-strategy-for-biologicals/register